Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Local immunologic reactions induced by CAPD].

B Faller1, J F Marichal, P Brignon

  • 1Service de Néphrologie-Hémodialyse, Hôpital Pasteur, Colmar.

Nephrologie
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.

Pharmaceutical research·2016
Same author

A 5-year prospective follow-up study in essential cryofibrinogenemia patients.

Autoimmunity reviews·2011
Same author

Familial membranous glomerulopathy, toxic exposure and/or genetic sensibility?

Clinical nephrology·2008
Same author

[Preanalytical variability of parathyroid hormone measurement in dialysis patients; application to Elecsys 2010 (Roche) automate].

Annales de biologie clinique·2008
Same author

[Low density lipoprotein apheresis therapy during pregnancy].

Presse medicale (Paris, France : 1983)·2003
Same author

[Treatment by LDL-apheresis during pregnancy].

Presse medicale (Paris, France : 1983)·2003
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Continuous peritoneal dialysis (CAPD) can trigger immune responses and inflammation, potentially leading to peritoneal fibrosis. This condition may cause loss of ultrafiltration and Sclerosing Encapsulating Peritonitis (SEP).

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Context:

  • Continuous peritoneal dialysis (CAPD) involves the peritoneal cavity, which is susceptible to bacterial contamination and dialysate presence.
  • These factors stimulate immunological responses, impacting antibacterial defenses like opsonins and cells.
  • Peritoneal effluent contains diluted IgG and fibronectin, with macrophages dominating peritoneal cells.

Purpose:

  • To investigate the immunological and cellular mechanisms underlying peritoneal fibrosis during CAPD.
  • To understand how chronic inflammation in the peritoneal cavity contributes to fibrosis and its complications.

Summary:

  • CAPD stimulates peritoneal immunological factors, including macrophages with potentially defective bactericidal activity.
  • Continuous dialysate presence induces chronic local inflammation, with macrophages and lymphocytes synthesizing IL-1, PGE2, and IFN-γ.

Related Experiment Videos

  • These mediators promote fibroblast proliferation in the submesothelial tissue, leading to progressive fibrosis, loss of ultrafiltration, and Sclerosing Encapsulating Peritonitis (SEP).

    • Impact:

    • Identifies key inflammatory mediators and cellular players in CAPD-associated peritoneal fibrosis.
    • Highlights the link between chronic inflammation, fibrosis, and severe complications like SEP.
    • Provides insights for potential therapeutic strategies to prevent or manage peritoneal fibrosis in CAPD patients.